Efficacy Of Felodipine In Hypertensive Patients
DOI:
https://doi.org/10.47144/phj.v26i3-4.247Keywords:
Efficacy Of Felodipine In Hypertensive PatientsAbstract
Introduction:
Vasodilators are used commonly as first line of treatment in patients with established hypertension as peripheral vascular resistance is usually inc reased in these patients. Felodipine, a dihydropyrid ine derivative, structurally related to nifidepine, inhibits vascular smooth muscle contractile activ ity.
Patients and Method:
Thirtytwo patients (21 females and 11 males) with mild to moderate hypertension were selected for this study. All patients were put on active treatm ent for 12 weeks after 2 weeks placebo treatm ent. Previously untreated patients or newly diagn osed patients were put on 5mg Felodipine/day for 2 weeks. If blood pressure was not controlled then the dose was increased to 10mg/day for another two weeks.
Discussion:
Beta blockers, or diuretics or methyldopa were used for a long time as the 1st drug of choice for treatment of hypertension. But now the trend is changing. Other drugs like vasodilators are in use now, some vasodilators have some limitations like hydraizine may cause systemic lupus erythmatos us. Prazosin dilates both arteries and veins which may cause orthostatic hypotension.
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/